Skip to content

Clinical trials

Completed Neoplasm Metastasis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Status: Completed Clear all

1,581 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200022
200132
200234
200348
200451
200560
200681
200773
200861
200986
201088
201188
201284
201392
201492
201560
201676
201765
201858
201947
202054
202161
202237
202328
202416
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,581

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center55
National Cancer Institute (NCI)49
Eli Lilly and Company48
Memorial Sloan Kettering Cancer Center29
Amgen27
AstraZeneca27
Novartis Pharmaceuticals23
H. Lee Moffitt Cancer Center and Research Institute22
Pfizer21
Dana-Farber Cancer Institute17

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis1,581
Neoplasms315
Breast Neoplasms246
Colorectal Neoplasms191
Carcinoma, Non-Small-Cell Lung123
Melanoma112
Prostatic Neoplasms111
Lung Neoplasms94
Recurrence91
Pancreatic Neoplasms85

Trials

Showing 26 to 50 of 1,581. Each trial links to its page on Pharma Observatory.

1,481 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.